文献速递消化道肿瘤与早癌消化内镜

根据种族和民族进行胃癌筛查的成本效益

Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.
PubMed 文献 · Gastroenterology · 2018-05-17

研究采用决策分析马尔可夫模型,比较50岁非西班牙裔白人、非西班牙裔黑人、西班牙裔和亚裔人群不接受筛查与两种内镜筛查策略的成本效益。结果显示,仅在发现肠上皮化生或更严重病变时继续监测的食管胃十二指肠镜筛查对非西班牙裔黑人、西班牙裔和亚裔具有成本效益,但对非西班牙裔白人无成本效益。

要点

  • 在支付意愿阈值10万美元/质量调整生命年下,非西班牙裔黑人、西班牙裔和亚裔的筛查具有成本效益。
  • 非西班牙裔白人的筛查成本为122,428美元/质量调整生命年,超过支付意愿阈值。
  • 模型对肠上皮化生患病率、从肠上皮化生到异型增生及局部和区域癌的转化率、内镜成本和切除成本敏感。

核心结论

  • 基于决策分析马尔可夫模型,在美国对高风险种族和民族进行内镜非贲门胃癌筛查可能具有成本效益。

研究设计与样本

  • 决策分析马尔可夫模型,基础病例为50岁非西班牙裔白人、非西班牙裔黑人、西班牙裔或亚裔个体。

主要发现

  • 与每2年筛查和不筛查相比,仅在指征明确时继续监测的筛查食管胃十二指肠镜对非西班牙裔黑人(80,278美元/质量调整生命年)、西班牙裔(76,070美元/质量调整生命年)和亚裔(71,451美元/质量调整生命年)具有成本效益。
  • 非西班牙裔白人的筛查成本为122,428美元/质量调整生命年,不具有成本效益。

关键数值与推荐

  • 支付意愿阈值为100,000美元/质量调整生命年。
  • 模型对肠上皮化生患病率、从肠上皮化生到异型增生及局部和区域癌的转化率、内镜成本和切除(内镜或手术)成本敏感。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: There are marked racial and ethnic differences in non-cardia gastric cancer prevalence within the United States. Although gastric cancer screening is recommended in some regions of high prevalence, screening is not routinely performed in the United States. Our objective was to determine whether selected non-cardia gastric cancer screening for high-risk races and ethnicities within the United States is cost effective. METHODS: We developed a decision analytic Markov model with the base case of a 50-year-old person of non-Hispanic white, non-Hispanic black, Hispanic, or Asian race or ethnicity. The cost effectiveness of a no-screening strategy (current standard) for non-cardia gastric cancer was compared with that of 2 endoscopic screening modalities initiated at the time of screening colonoscopy for colorectal cancer: upper esophagogastroduodenoscopy with biopsy examinations and continued surveillance only if intestinal metaplasia or more severe pathology is identified or esophagogastroduodenoscopy with biopsy examinations continued every 2 years even in the absence of identified pathology. We used prevalence rates, transition probabilities, costs, and quality-adjusted life years (QALYs) from publications and public data sources. Outcome measures were reported in incremental cost-effectiveness ratios, with a willingness-to-pay threshold of $100,000/QALY. RESULTS: Compared with biennial and no screening, screening esophagogastroduodenoscopy with continued surveillance only when indicated was cost effective for non-Hispanic blacks ($80,278/QALY), Hispanics ($76,070/QALY), and Asians ($71,451/QALY), but not for non-Hispanic whites ($122,428/QALY). The model was sensitive to intestinal metaplasia prevalence, transition rates from intestinal metaplasia to dysplasia to local and regional cancer, cost of endoscopy, and cost of resection (endoscopic or surgical). CONCLUSIONS: Based on a decision analytic Markov model, endoscopic non-cardia gastric cancer screening for high-risk races and ethnicities could be cost effective in the United States.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Saumoy M, Schneider Y, Shen N, et al. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Gastroenterology. 2018. PMID: 29778607. doi:10.1053/j.gastro.2018.05.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。